ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
farrier
|
1.0K |
430K |
17 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
430K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
farrier
|
1.0K |
333K |
18 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
1.0K
|
333K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Emergency Access to Rem-L
|
|
farrier
|
147 |
38K |
39 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
147
|
38K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
farrier
|
91 |
30K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
farrier
|
91 |
30K |
3 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
farrier
|
91 |
30K |
1 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
farrier
|
91 |
30K |
8 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
8
|
|